Status:
COMPLETED
Open-Label Extension of Other SZ1839 (Iressa) Trials
Lead Sponsor:
AstraZeneca
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A trial to assess patients who have been treated with Iressa in a previous clinical trial and may benefit from continued treatment with Iressa.
Eligibility Criteria
Inclusion
- Received treatment in a previous Iressa clinical trial
- Provided Informed Consent to participate in the trial
- 30 days or less since completing the previous Iressa trial.
Exclusion
- Radiotherapy completed more than 14 days before starting treatment in this trial
- Incomplete healing from prior surgery
- Withdrawal from previous Iressa trial due to unacceptable toxicity to major organs
Key Trial Info
Start Date :
February 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2003
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00635973
Start Date
February 1 2000
End Date
October 1 2003
Last Update
April 22 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.